Abeona Therapeutics (ABEO)CEO sold ~$120K

~$120K

Approx. value · 25K sh @ $4.78

1.36M

Holds after · shares reported

Traded

Mar 31, 2025

Filed

Mar 31, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jan 29, 2025InsiderDirector sold ~$22K of ABEO shares in the open market
2. Mar 31, 2025 · this disclosureInsiderCEO sold ~$120K of ABEO shares in the open market

What came next

1. May 16, 2025InsiderDirector sold ~$45K of ABEO shares in the open market
2. May 27, 2025InsiderDirector sold ~$13K of ABEO shares in the open market
3. Jun 6, 2025Insider · 3 peopleInsiders: 3 sales (~$534K)
4. Jul 8, 2025InsiderDirector sold ~$30K of ABEO shares in the open market
5. Jul 9, 2025Insider · 6 peopleInsiders: 6 sales (~$874K)
6. Jul 22, 2025InsiderCFO sold ~$10K of ABEO shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Abeona Therapeutics

For Abeona Therapeutics, OQRO holds 4 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABEO page.

Other recent filings by Vishwas Seshadri, Chief Executive Officer

• SEC Form 4 at Abeona Therapeutics (ABEO)Sep 30, 2026
• SEC Form 4 at Abeona Therapeutics (ABEO)Jul 10, 2025
• SEC Form 4 at Abeona Therapeutics (ABEO)Jun 6, 2025

The full history of Vishwas Seshadri, Chief Executive Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Abeona Therapeutics

• SEC Form 4Sep 30, 2026
• SEC Form 4Sep 30, 2026
• SEC Form 4Sep 30, 2026
• SEC Form 4Sep 30, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRMay 15, 2026

Everything OQRO holds on this company is on its ABEO page.